These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26098642)

  • 1. The Possible Mechanism of Idiosyncratic Lapatinib-Induced Liver Injury in Patients Carrying Human Leukocyte Antigen-DRB1*07:01.
    Hirasawa M; Hagihara K; Okudaira N; Izumi T
    PLoS One; 2015; 10(6):e0130928. PubMed ID: 26098642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Silico and In Vitro Analysis of Interaction between Ximelagatran and Human Leukocyte Antigen (HLA)-DRB1*07:01.
    Hirasawa M; Hagihara K; Abe K; Ando O; Hirayama N
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28338626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of Nevirapine with the Peptide Binding Groove of HLA-DRB1*01:01 and Its Effect on the Conformation of HLA-Peptide Complex.
    Hirasawa M; Hagihara K; Abe K; Ando O; Hirayama N
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29867033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective validation of HLA-DRB1*07:01 allele carriage as a predictive risk factor for lapatinib-induced liver injury.
    Schaid DJ; Spraggs CF; McDonnell SK; Parham LR; Cox CJ; Ejlertsen B; Finkelstein DM; Rappold E; Curran J; Cardon LR; Goss PE
    J Clin Oncol; 2014 Aug; 32(22):2296-303. PubMed ID: 24687830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lapatinib-induced liver injury characterized by class II HLA and Gilbert's syndrome genotypes.
    Spraggs CF; Parham LR; Hunt CM; Dollery CT
    Clin Pharmacol Ther; 2012 Apr; 91(4):647-52. PubMed ID: 22357454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive genome-wide evaluation of lapatinib-induced liver injury yields a single genetic signal centered on known risk allele HLA-DRB1*07:01.
    Parham LR; Briley LP; Li L; Shen J; Newcombe PJ; King KS; Slater AJ; Dilthey A; Iqbal Z; McVean G; Cox CJ; Nelson MR; Spraggs CF
    Pharmacogenomics J; 2016 Apr; 16(2):180-5. PubMed ID: 25987243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No Evidence for Drug-Specific Activation of Circulating T Cells from Patients with HLA-DRB1*07:01-Restricted Lapatinib-Induced Liver Injury.
    Faulkner L; Meng X; Naisbitt DJ; Spraggs CF; Park BK
    Chem Res Toxicol; 2016 Dec; 29(12):2111-2113. PubMed ID: 27989141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-Wide Association Studies for Idiosyncratic Drug-Induced Hepatotoxicity: Looking Back-Looking Forward to Next-Generation Innovation.
    Petros Z; Makonnen E; Aklillu E
    OMICS; 2017 Mar; 21(3):123-131. PubMed ID: 28253087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of the HLA-DRB1*07:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanes.
    Spraggs CF; Parham LR; Briley LP; Warren L; Williams LS; Fraser DJ; Jiang Z; Aziz Z; Ahmed S; Demetriou G; Mehta A; Jackson N; Byrne J; Andersson M; Toi M; Harris L; Gralow J; Zujewski JA; Crescenzo R; Armour A; Perez E; Piccart M
    Pharmacogenomics J; 2018 May; 18(3):480-486. PubMed ID: 28786423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DRB1*07:01 and lapatinib-induced hepatotoxicity: a systematic review and meta-analysis.
    Tangamornsuksan W; Kongkaew C; Scholfield CN; Subongkot S; Lohitnavy M
    Pharmacogenomics J; 2020 Feb; 20(1):47-56. PubMed ID: 31383939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rash in lapatinib-treated patients is not associated with human leukocyte antigen polymorphisms.
    Parham LR; Briley LP; King KS; Byrne J; Rappold E; Goss PE; Spraggs CF
    Pharmacogenomics; 2015; 16(11):1227-9. PubMed ID: 26265235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The amino acid variation within the binding pocket 7 and 9 of HLA-DRB1 molecules are associated with primary Sjögren's syndrome.
    Huang R; Yin J; Chen Y; Deng F; Chen J; Gao X; Liu Z; Yu X; Zheng J
    J Autoimmun; 2015 Feb; 57():53-9. PubMed ID: 25582848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease.
    Andrade RJ; Lucena MI; Alonso A; García-Cortes M; García-Ruiz E; Benitez R; Fernández MC; Pelaez G; Romero M; Corpas R; Durán JA; Jiménez M; Rodrigo L; Nogueras F; Martín-Vivaldi R; Navarro JM; Salmerón J; de la Cuesta FS; Hidalgo R
    Hepatology; 2004 Jun; 39(6):1603-12. PubMed ID: 15185301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homology modelling of frequent HLA class-II alleles: A perspective to improve prediction of HLA binding peptide and understand the HLA associated disease susceptibility.
    Kashyap M; Farooq U; Jaiswal V
    Infect Genet Evol; 2016 Oct; 44():234-244. PubMed ID: 27421208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic peptide molecular recognition by the DRB1-DQB1 haplotype modulates multiple sclerosis susceptibility.
    Kumar A; Melis P; Genna V; Cocco E; Marrosu MG; Pieroni E
    Mol Biosyst; 2014 Aug; 10(8):2043-54. PubMed ID: 24853027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based selection of human metabolite binding P4 pocket of DRB1*15:01 and DRB1*15:03, with implications for multiple sclerosis.
    Misra MK; Damotte V; Hollenbach JA
    Genes Immun; 2019 Jan; 20(1):46-55. PubMed ID: 29362509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding Patterns Associated Aß-HSP60 p458 Conjugate to HLA-DR-DRB Allele of Human in Alzheimer's Disease: An In Silico Approach.
    Padmadas N; Panda PK; Durairaj S
    Interdiscip Sci; 2018 Mar; 10(1):93-104. PubMed ID: 27106586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury.
    Donaldson PT; Daly AK; Henderson J; Graham J; Pirmohamed M; Bernal W; Day CP; Aithal GP
    J Hepatol; 2010 Dec; 53(6):1049-53. PubMed ID: 20800921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of human leukocyte antigen class II DRB1*1602 haplotype in Greek patients with myelodysplastic syndrome and of DRB1*1501 in the low-risk subgroup.
    Kritikou-Griva E; Spyropoulou-Vlachou M; Tsagarakis NJ; Goumakou E; Vrani V; Galanopoulos A; Papadhimitriou SI; Androutsos G; Paterakis G; Stavropoulos-Giokas C
    Hum Immunol; 2012 Mar; 73(3):278-81. PubMed ID: 22244918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
    Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
    Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.